drugset / Trial / NCT00545298

Safety and Efficacy of Gaseous Nitric Oxide on Venous Stasis Leg Ulcers

NCT00545298

Phase 2 Terminated 4 enrolled Nitric BioTherapeutics, Inc
RandomizedParallel-groupOpen-labelTreatment

Summary

This study will test the safety and efficacy of nitric oxide gas in the treatment of venous leg ulcers

Timeline

Start
2007-10
Primary completion
2008-11
Completion
2008-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Nitric Oxide Other / unclassified 25 ppm Topical
Subject Nitric Oxide Other / unclassified 200 ppm Topical

Indications